Salmonella Enteritidis flagellin antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Salmonella Enteritidis flagellin antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease salmonellosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Avian/Bird/Poultry disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P191-Tg001-Ag01	Recombinant Salmonella Enteritidis flagellin protein	$3090.00
GMP-VT-P191-Tg001-Ab01	Anti-Salmonella Enteritidis flagellin mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P191-Tg001-Ab02	Anti-Salmonella Enteritidis flagellin mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P191-Tg001-Ab03	Anti-Salmonella Enteritidis flagellin human monoclonal antibody (mAb)	$3090.00
GMP-VT-P191-Tg001-Ab04	Anti-Salmonella Enteritidis flagellin human monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P191-Tg001-Ag01
Product Name	Recombinant Salmonella Enteritidis flagellin protein
Pathogen	Salmonella Enteritidis
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Salmonella Enteritidis flagellin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Salmonella Enteritidis level test of animal Avian/Bird/Poultry infectious disease with salmonellosis.
Tag	His
Product description	Recombinant Salmonella Enteritidis flagellin proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P191-Tg001-Ab01,GMP-VT-P191-Tg001-Ab02
Pathogen	Salmonella Enteritidis
Product Name	Anti-Salmonella Enteritidis flagellin mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Salmonella Enteritidis flagellin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Salmonella Enteritidis antibodies in Salmonella Enteritidis level test of animal Avian/Bird/Poultry infectious disease with salmonellosis.
Product description	Anti-Salmonella Enteritidis flagellin mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Salmonella Enteritidis antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P191-Tg001-Ab03,GMP-VT-P191-Tg001-Ab04
Pathogen	Salmonella Enteritidis
Product Name	Anti-Salmonella Enteritidis flagellin human monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Recombinant Salmonella Enteritidis flagellin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Salmonella Enteritidis antibodies in Salmonella Enteritidis level test of animal Avian/Bird/Poultry infectious disease with salmonellosis.
Product description	Anti-Salmonella Enteritidis flagellin mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen Information

Salmonella Enteritidis, scientifically designated as S. Enteritidis, is a Gram-negative, rod-shaped bacterium that holds a prominent position within the Salmonella genus. This pathogen is well-recognized for its pathogenicity, particularly in the context of causing foodborne illnesses in humans. In this detailed exploration, we delve into various aspects of Salmonella Enteritidis, encompassing its classification, genetic structure, host specificity, associated diseases, and diagnostic methods.

Pathogen Classification:

S. Enteritidis is unequivocally classified as a prokaryotic bacterium, signifying its status as a single-celled organism without a nucleus or membrane-bound organelles. Taxonomically, this bacterium is situated within the family Enterobacteriaceae, which forms part of the phylum Proteobacteria.

Pathogen Structure:

The genetic architecture of Salmonella Enteritidis is intricate and multifaceted. A pivotal element of its genetic makeup is the Salmonella Pathogenicity Island 1 (SPI-1). SPI-1 represents a genomic region containing genes encoding the Type III secretion system, a crucial apparatus employed by the pathogen for host cell invasion. The invasion process itself is orchestrated by various proteins, among which SipA, SipB, SipC, and SipD, all products of SPI-1, play essential roles. These proteins actively contribute to the bacterium's virulence, mediating interactions with host cells and promoting pathogenicity.

Host Specificity and Associated Diseases:

Salmonella Enteritidis primarily targets two main hosts: humans and poultry, with a pronounced predilection for chickens and their eggs. In addition to its primary hosts, this bacterium has the potential to infect various other animal species, a feature that underscores its significance as a zoonotic pathogen.

The diseases attributed to Salmonella Enteritidis are diverse, although its most common clinical manifestation in humans is gastroenteritis. Gastroenteritis is characterized by a range of gastrointestinal symptoms, including diarrhea, abdominal discomfort, fever, and vomiting. In severe cases, Salmonella Enteritidis infections can progress to systemic infections, notably septicemia, which involves the bacterium's dissemination throughout the bloodstream. Such systemic infections pose a substantial health threat, potentially leading to life-threatening complications.

Diagnostic Methods:

Efficient and accurate diagnostic methods for Salmonella Enteritidis are pivotal for public health, food safety, and disease management. These methods encompass both conventional culture-based techniques and advanced molecular approaches, with a significant focus on Polymerase Chain Reaction (PCR).

Culture-Based Techniques: Conventional culture-based methods involve isolating the bacterium from clinical or food samples. Selective culture media tailored to Salmonella species are utilized to promote bacterial growth. Confirmation of the pathogen's identity is subsequently achieved through biochemical tests.

Molecular Methods, Including PCR: Molecular diagnostic techniques, especially PCR, have revolutionized the rapid and specific detection of Salmonella Enteritidis. PCR assays are designed to target specific genes or genetic sequences unique to the pathogen. Among the most commonly targeted genes are invA, a gene highly conserved among Salmonella species, and rfbJ, a gene that serves as a specific marker for S. Enteritidis. Additional targets may encompass genes such as ttrA and sefA, which are selected for their diagnostic sensitivity and specificity in identifying S. Enteritidis.

About GDU